There are a number of reports where ApoE has been successfully administered via direct gene delivery or virally in a variety of disease models including Alzheimer's disease [11], hypercholesterolemia [33-36], hyperlipidemia [37], atherosclerosis [37-39], experimental stroke [40] and hematopoietic diseases [41]. The gene discussed is APOE; the disease is atherosclerosis.